BR9907259A - Compostos para terapia e diagnóstico de câncer de pulmão e processos para o seu uso - Google Patents
Compostos para terapia e diagnóstico de câncer de pulmão e processos para o seu usoInfo
- Publication number
- BR9907259A BR9907259A BR9907259-9A BR9907259A BR9907259A BR 9907259 A BR9907259 A BR 9907259A BR 9907259 A BR9907259 A BR 9907259A BR 9907259 A BR9907259 A BR 9907259A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- lung cancer
- processes
- diagnosis
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1502998A | 1998-01-28 | 1998-01-28 | |
US1502298A | 1998-01-28 | 1998-01-28 | |
US4083198A | 1998-03-18 | 1998-03-18 | |
US4082898A | 1998-03-18 | 1998-03-18 | |
US12219298A | 1998-07-23 | 1998-07-23 | |
US12219198A | 1998-07-23 | 1998-07-23 | |
US21924598A | 1998-12-22 | 1998-12-22 | |
PCT/US1999/001642 WO1999038973A2 (en) | 1998-01-28 | 1999-01-26 | Compounds for therapy and diagnosis of lung cancer and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9907259A true BR9907259A (pt) | 2002-01-22 |
Family
ID=27567530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9907259-9A BR9907259A (pt) | 1998-01-28 | 1999-01-26 | Compostos para terapia e diagnóstico de câncer de pulmão e processos para o seu uso |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1051489A2 (es) |
JP (1) | JP2002516659A (es) |
KR (1) | KR20010034436A (es) |
CN (1) | CN1292029A (es) |
AR (1) | AR014514A1 (es) |
AU (1) | AU2344399A (es) |
BR (1) | BR9907259A (es) |
CA (1) | CA2319117A1 (es) |
ID (1) | ID27813A (es) |
IL (1) | IL137417A0 (es) |
NO (1) | NO20003853L (es) |
WO (1) | WO1999038973A2 (es) |
ZA (1) | ZA99693B (es) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6821518B1 (en) | 1998-03-18 | 2004-11-23 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US7258860B2 (en) | 1998-03-18 | 2007-08-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6531315B1 (en) | 1998-03-18 | 2003-03-11 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6518256B1 (en) | 1998-03-18 | 2003-02-11 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6737514B1 (en) | 1998-12-22 | 2004-05-18 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6706262B1 (en) | 1998-03-18 | 2004-03-16 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6482597B1 (en) | 1999-12-17 | 2002-11-19 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6660838B1 (en) | 1998-03-18 | 2003-12-09 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6696247B2 (en) | 1998-03-18 | 2004-02-24 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6960570B2 (en) | 1998-03-18 | 2005-11-01 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6426072B1 (en) | 2000-08-02 | 2002-07-30 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US7579160B2 (en) | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
US7049063B2 (en) | 1998-03-18 | 2006-05-23 | Corixa Corporation | Methods for diagnosis of lung cancer |
US6312695B1 (en) | 1998-03-18 | 2001-11-06 | Corixa Corporation | Compounds and methods for therapy of lung cancer |
EP1526383A3 (en) * | 1998-08-31 | 2005-11-16 | Pfizer Products Inc. | Diarylsulfonylurea binding proteins |
EP0987552A3 (en) | 1998-08-31 | 2000-06-07 | Pfizer Products Inc. | Diarylsulfonylurea binding proteins |
CA2348733A1 (en) * | 1998-10-28 | 2000-05-11 | Rigel Pharmaceuticals, Inc. | Novel compositions and methods of screening for t-cell and b-cell activation modulators |
US6709855B1 (en) | 1998-12-18 | 2004-03-23 | Scios, Inc. | Methods for detection and use of differentially expressed genes in disease states |
WO2000035473A2 (en) * | 1998-12-18 | 2000-06-22 | Scios Inc. | Methods for detection and use of differentially expressed genes in disease states |
WO2000046370A1 (en) * | 1999-02-04 | 2000-08-10 | Board Of Trustees Of The University Of Illinois | P37ing1 compositions and methods of use |
US6448221B1 (en) | 1999-02-19 | 2002-09-10 | Zymogenetics, Inc. | Methods of promoting blood flow within the vasculature of a mammal |
US6544946B1 (en) | 1999-02-19 | 2003-04-08 | Zymogenetics, Inc. | Inhibitors for use in hemostasis and immune function |
AU4185100A (en) * | 1999-04-02 | 2000-10-23 | Corixa Corporation | Compounds for therapy and diagnosis of lung cancer and methods for their use |
KR20020007354A (ko) * | 1999-04-02 | 2002-01-26 | 길리스 스티브 | 폐암의 치료 및 진단에 유용한 화합물 및 방법 |
US6759508B2 (en) | 2000-09-01 | 2004-07-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6444425B1 (en) | 1999-04-02 | 2002-09-03 | Corixa Corporation | Compounds for therapy and diagnosis of lung cancer and methods for their use |
US6686447B1 (en) | 1999-06-30 | 2004-02-03 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6858204B2 (en) | 1999-06-30 | 2005-02-22 | Corxia Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6746846B1 (en) | 1999-06-30 | 2004-06-08 | Corixa Corporation | Methods for diagnosing lung cancer |
US6504010B1 (en) | 1999-06-30 | 2003-01-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6914132B1 (en) | 1999-06-30 | 2005-07-05 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US20030125245A1 (en) | 1999-06-30 | 2003-07-03 | Tongtong Wang | Compositions and methods for therapy and diagnosis of lung cancer |
US20030211510A1 (en) | 1999-06-30 | 2003-11-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6509448B2 (en) | 1999-06-30 | 2003-01-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6667154B1 (en) | 1999-06-30 | 2003-12-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
MXPA02000192A (es) | 1999-06-30 | 2004-08-12 | Corixa Corp | Composiciones y metodos para la terapia y diagnostico de cancer de pulmon. |
CA2309313A1 (en) * | 1999-08-05 | 2001-02-05 | Board Of Trustees Of The University Of Arkansas | Stimulation of the immune response by human dendritic cell manipulation |
WO2001021653A2 (en) * | 1999-09-23 | 2001-03-29 | Corixa Corporation | Ovarian tumor antigen and methods of use therefor |
EP1686134A3 (en) * | 1999-12-01 | 2006-08-09 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
JP2004518401A (ja) * | 2000-04-14 | 2004-06-24 | インサイト・ゲノミックス・インコーポレイテッド | ヒトの生殖に関する分子 |
WO2002002623A2 (en) * | 2000-06-29 | 2002-01-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
EP1343886A2 (en) * | 2000-07-11 | 2003-09-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
WO2002006455A2 (en) * | 2000-07-19 | 2002-01-24 | Bayer Aktiengesellschaft | Regulation of human airway trypsin protease-like enzyme |
EP1314779B1 (en) * | 2000-08-28 | 2007-10-03 | Teijin Limited | Airway-specific trypsin-like enzymes and method of using the same |
US7348406B2 (en) | 2001-01-16 | 2008-03-25 | Serono Genetics Institute S.A. | Metabolic gene polynucleotides and polypeptides and uses thereof |
GB0101300D0 (en) * | 2001-01-18 | 2001-02-28 | Univ Cambridge Tech | Primordial germ cell genes |
US7226994B2 (en) | 2001-01-18 | 2007-06-05 | Cambridge University Technical Services Limited | Cell surface expressed marker of pluripotency |
US20050085627A1 (en) | 2001-06-21 | 2005-04-21 | Youming Zhang | Atopy |
AU2003243151A1 (en) | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
AU2007216892B2 (en) * | 2002-08-16 | 2011-02-10 | Agensys, Inc. | Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer |
US20060094649A1 (en) * | 2002-12-10 | 2006-05-04 | Keogh Elissa A | Hla-a1,-a2,-a3,-a24,-b7, and-b44 tumor associated antigen peptides and compositions |
EP1831684A4 (en) * | 2004-11-30 | 2009-03-11 | Veridex Llc | PROGNOSTICS OF LUNG CANCER |
WO2007047764A2 (en) | 2005-10-17 | 2007-04-26 | Sloan Kettering Institute For Cancer Research | Wt1 hla class ii-binding peptides and compositions and methods comprising same |
US9265816B2 (en) | 2006-04-10 | 2016-02-23 | Sloan Kettering Institute For Cancer Research | Immunogenic WT-1 peptides and methods of use thereof |
EP2423332A1 (en) * | 2006-08-25 | 2012-02-29 | Oncotherapy Science, Inc. | Prognostic markers and therapeutic targets for lung cancer |
EP2334826A4 (en) * | 2008-09-12 | 2012-01-25 | Cancer Res Initiative Foundation | PROCEDURE FOR THE DETECTION AND DIAGNOSIS OF ORAL AND NASOPHARYNGEAL TUMORS |
CN101891802B (zh) * | 2009-08-11 | 2011-11-16 | 武汉凯泰新生物技术有限公司 | 治疗或预防癌症的多肽或衍生产品及其应用 |
CN101921313B (zh) * | 2010-04-07 | 2012-02-29 | 武汉凯泰新生物技术有限公司 | 治疗或预防癌症的多肽或其衍生产品及应用 |
GB201104286D0 (en) * | 2011-03-15 | 2011-04-27 | Randox Lab Ltd | Glutathione S-transferase omega 1 wild type specific antibody |
EP2754713B1 (en) * | 2011-09-09 | 2019-07-10 | Trans Genic Inc. | ANTIBODY AGAINST MUTANT alpha-ACTININ-4 |
JP6282598B2 (ja) | 2012-01-13 | 2018-02-21 | メモリアル スローン ケタリング キャンサー センター | 免疫原性wt1ペプチド及びその使用方法 |
US10815273B2 (en) | 2013-01-15 | 2020-10-27 | Memorial Sloan Kettering Cancer Center | Immunogenic WT-1 peptides and methods of use thereof |
CA2898099A1 (en) | 2013-01-15 | 2014-07-24 | David A. Scheinberg | Immunogenic wt-1 peptides and methods of use thereof |
US20170319722A1 (en) * | 2016-04-04 | 2017-11-09 | Indi Molecular, Inc. | Cd8-specific capture agents, compositions, and methods of using and making |
CN110139927B (zh) * | 2016-11-16 | 2024-06-07 | 加利福尼亚大学董事会 | Crispr-cas9抑制剂 |
CN110669104B (zh) * | 2019-10-30 | 2021-11-05 | 上海交通大学 | 一组来源于人外周血单核细胞的标志物及其应用 |
CN112500467B (zh) * | 2020-12-14 | 2022-05-24 | 上海交通大学 | 一种生物活性肽rrecpsdecgagvf及其制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589579A (en) * | 1994-07-19 | 1996-12-31 | Cytoclonal Pharmaceutics, Inc. | Gene sequence and probe for a marker of non-small cell lung carinoma |
US5633161A (en) * | 1995-03-29 | 1997-05-27 | Millennium Pharmaceuticals, Inc. | Murine gene fomy030 coding for tumor progression inhibitor |
-
1999
- 1999-01-20 ID IDW20001646A patent/ID27813A/id unknown
- 1999-01-26 CN CN99803446A patent/CN1292029A/zh active Pending
- 1999-01-26 KR KR1020007008209A patent/KR20010034436A/ko not_active Application Discontinuation
- 1999-01-26 AU AU23443/99A patent/AU2344399A/en not_active Abandoned
- 1999-01-26 WO PCT/US1999/001642 patent/WO1999038973A2/en not_active Application Discontinuation
- 1999-01-26 BR BR9907259-9A patent/BR9907259A/pt not_active Application Discontinuation
- 1999-01-26 IL IL13741799A patent/IL137417A0/xx unknown
- 1999-01-26 EP EP99903417A patent/EP1051489A2/en not_active Withdrawn
- 1999-01-26 JP JP2000529432A patent/JP2002516659A/ja not_active Withdrawn
- 1999-01-26 CA CA002319117A patent/CA2319117A1/en not_active Abandoned
- 1999-01-28 AR ARP990100346A patent/AR014514A1/es unknown
- 1999-01-28 ZA ZA9900693A patent/ZA99693B/xx unknown
-
2000
- 2000-07-27 NO NO20003853A patent/NO20003853L/no unknown
Also Published As
Publication number | Publication date |
---|---|
ID27813A (id) | 2001-04-26 |
WO1999038973A3 (en) | 1999-12-09 |
NO20003853L (no) | 2000-09-27 |
ZA99693B (en) | 1999-10-21 |
KR20010034436A (ko) | 2001-04-25 |
AR014514A1 (es) | 2001-02-28 |
JP2002516659A (ja) | 2002-06-11 |
IL137417A0 (en) | 2001-07-24 |
CN1292029A (zh) | 2001-04-18 |
EP1051489A2 (en) | 2000-11-15 |
CA2319117A1 (en) | 1999-08-05 |
WO1999038973A2 (en) | 1999-08-05 |
AU2344399A (en) | 1999-08-16 |
NO20003853D0 (no) | 2000-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9907259A (pt) | Compostos para terapia e diagnóstico de câncer de pulmão e processos para o seu uso | |
BR0009505A (pt) | Compostos e processos para terapia e diagnóstico de câncer de pulmão | |
BR9808881A (pt) | Compostos para imunoterapia de câncer de próstata e métodos para seu uso | |
BR9908823A (pt) | Compostos e processos para terapia e diagnóstico de câncer de pulmão | |
WO1999033869A3 (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use | |
NZ516381A (en) | Lung tumor proteins in the therapy and diagnosis of lung cancer | |
TW581808B (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
ES2141128T3 (es) | Combinacion de agentes anti-hormonales y moleculas de fijacion. | |
DE69937294D1 (de) | Von cyclophilin b abstammende tumorantigen-peptide | |
BR9807734A (pt) | Composto para imunodiagnose de câncer de próstata e métodos para o uso dos memos | |
IL153996A0 (en) | Polypeptides containing at least a portion of an ovarian carcinoma protein, polynucleotides encoding the same and pharmaceutical compositions containing the same | |
FI961755A (fi) | Yhdistelmäadenovirusvektori ja menetelmiä sen käyttämiseksi | |
FI955552A0 (fi) | Adenoviraalisia eläinperäisiä vektoreita ja niiden käyttö geeniterapiassa | |
DE69738754D1 (de) | Hemmer der interaktion zwischen p53 und mdm2 | |
BR0211546A (pt) | Composição farmacêutica e/ou de diagnóstico e uso de microrganismo ou célula | |
BR0009608A (pt) | Compostos para imunoterapia e diagnóstico de câncer de mama e métodos para sua utilização | |
NO305903B1 (no) | Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
CA2234263A1 (fr) | Composition pharmaceutique contre les tumeurs et infections a papillomavirus | |
DK1141326T3 (da) | Human Akt-3 | |
YU60199A (sh) | Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji | |
BR0207327A (pt) | Amino derivados de biotina e seus conjugados com agentes quelantes macrocìclicos | |
EP1792988A3 (en) | Compounds and methods for therapy and diagnosis of lung cancer | |
CO5050254A1 (es) | Compuestos para el tratamiento y diagnostico del cancer de pulmon | |
CO5241295A1 (es) | Compuestos para inmunoterapia y para el diagnostico del can- cer de mama y metodos para su utilizacion | |
ITMI922332A1 (it) | Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |